“The details in this new paper, combined with clinical trial data, show for the first time that an amyloid disease can be successfully treated by reducing the rate of amyloid formation,” says Professor Jeffery W. Kelly.
“We are delighted to contribute to The Scripps Research Institute’s important scientific and educational work,” says Clare O’Keeffe, executive trustee of the foundation.
The award, which is shared with British biochemist Sir Gregory Winter, is bestowed for findings that “represent a significant contribution to the progress and welfare of mankind.”
San Diego medtech entrepreneur Peter Farrell and Palm Beach real estate executive and entrepreneur Richard Sloane are the newest members of the Scripps Research Board.